Home Cart 0 Sign in  

[ CAS No. 189249-10-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 189249-10-3
Chemical Structure| 189249-10-3
Structure of 189249-10-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 189249-10-3 ]

Related Doc. of [ 189249-10-3 ]

Alternatived Products of [ 189249-10-3 ]

Product Details of [ 189249-10-3 ]

CAS No. :189249-10-3 MDL No. :MFCD02682328
Formula : C20H19NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :GOUUPUICWUFXPM-SGTLLEGYSA-N
M.W : 353.37 Pubchem ID :11902905
Synonyms :

Calculated chemistry of [ 189249-10-3 ]

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.3
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 97.84
TPSA : 87.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : 2.38
Log Po/w (WLOGP) : 2.07
Log Po/w (MLOGP) : 1.97
Log Po/w (SILICOS-IT) : 1.76
Consensus Log Po/w : 2.01

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.54
Solubility : 0.101 mg/ml ; 0.000287 mol/l
Class : Soluble
Log S (Ali) : -3.85
Solubility : 0.05 mg/ml ; 0.000141 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.79
Solubility : 0.0572 mg/ml ; 0.000162 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.98

Safety of [ 189249-10-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 189249-10-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 189249-10-3 ]

[ 189249-10-3 ] Synthesis Path-Downstream   1~22

  • 1
  • [ 2592-18-9 ]
  • (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid [ No CAS ]
  • [ 189249-10-3 ]
  • [ 296774-48-6 ]
  • FmocThr(OtBu)OH FmocOrn(Aloc)OH2,4,5-trichlorophenyl 4"-pentyloxyterphenoate [ No CAS ]
  • C57H73N7O14 [ No CAS ]
  • 2
  • [ 593-51-1 ]
  • [ 189249-10-3 ]
  • [ 847978-69-2 ]
  • 4
  • [ 189249-10-3 ]
  • (2S,4S)-1-((S)-2-Amino-3-phenyl-propionyl)-4-tert-butoxy-pyrrolidine-2-carboxylic acid methylamide [ No CAS ]
  • 5
  • [ 189249-10-3 ]
  • (2S,4S)-1-((S)-2-Acetylamino-3-phenyl-propionyl)-4-hydroxy-pyrrolidine-2-carboxylic acid methylamide [ No CAS ]
  • 6
  • [ 189249-10-3 ]
  • (2S,4S)-1-((S)-2-Acetylamino-3-phenyl-propionyl)-4-tert-butoxy-pyrrolidine-2-carboxylic acid methylamide [ No CAS ]
  • 8
  • [ 189249-10-3 ]
  • [ 847978-87-4 ]
  • 9
  • [ 189249-10-3 ]
  • (2S,4S)-4-tert-Butoxy-pyrrolidine-2-carboxylic acid methylamide [ No CAS ]
  • 10
  • [ 189249-10-3 ]
  • [ 1235447-41-2 ]
YieldReaction ConditionsOperation in experiment
36% With 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride; In dichloromethane; at 0 - 20℃; for 61h; Examples 2-10. Preparation of 4-fluoropyrrolidine-2-carbonyl fluoride compounds (Ia), (Ib), (Ic), (Id), and (If).[0086] 4-Fluoropyrrolidine-2-carbonyl fluoride compounds (Ia), (Ib), (Ic), (Id), and(If) were prepared by reaction of the corresponding 4-hydroxypyrrolidine-2-carboxylic acid compound with a fluorinating agent in the same manner as described in Example 1. The results and reaction conditions are shown in Table 3 together with those of Example 1.
  • 11
  • [ 29022-11-5 ]
  • [ 35661-60-0 ]
  • [ 71989-23-6 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 102971-73-3 ]
  • [ 77128-72-4 ]
  • [ 189249-10-3 ]
  • [ 1190083-09-0 ]
  • 12
  • 2-chlorotrityl chloride polystyrene resin [ No CAS ]
  • [ 850863-89-7 ]
  • [ 29022-11-5 ]
  • [ 68858-20-8 ]
  • [ 35661-60-0 ]
  • [ 71989-31-6 ]
  • [ 71989-33-8 ]
  • [ 71989-18-9 ]
  • [ 103213-32-7 ]
  • [ 71989-35-0 ]
  • [ 132388-59-1 ]
  • [ 143824-78-6 ]
  • [ 189249-10-3 ]
  • H-Gly-Thr(OtBu)-Cys(Trt)-Asn(Trt)-Thr(OtBu)-Pro-Gly-Cys(Trt)-Thr(OtBu)-Cys(Trt)-Ser(OtBu)-Trp(Boc)-[(4S)-4-hydroxy-L-proline]-Val-Cys(Trt)-Thr(OtBu)-Arg(Pbf)-Asn(Trt)-Gly-Leu-Pro-Val-Cys(Trt)-Gly-Glu(OtBu)-Thr(OtBu)-Cys(Trt)-Val-Gly-OH [ No CAS ]
YieldReaction ConditionsOperation in experiment
General procedure: Solid phase peptide synthesis Linear peptides were synthesized on 2-chlorotrityl chloride (2CTC) resin. Couplings were performed using 4 equiv of Fmoc-protected amino acid, 3 equiv of O-(1H-6-chlorobenzotriazol-1-y1)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HCTU), and 6 equiv of N,N-diisopropylethylamine (DIPEA) in dimethylformamide (DMF) for 2*10 min. Fmoc deprotection was carried out with 30% (v/v) piperidine in DMF. After each coupling and deprotection step, the peptide-resin was washed with DMF (3*), dichloromethane (DCM) (3*), and DMF (3*). The peptide-resin was treated with 1% (v/v) TFA (trifluoroacetic acid) in DCM (5 mL for 5 min, 10 times), draining the vessel after each cycle into a 1:1 mixture of MeCN/H2O (100 mL). DCM was removed in vacuo and the solutions lyophilized to afford the crude linear peptide.
  • 13
  • [ 189249-10-3 ]
  • C33H45N3O6 [ No CAS ]
  • 14
  • [ 189249-10-3 ]
  • N-(9-fluorenylmethoxycarbonyl)-(2S,4S)-4-tert-butoxyproline [ No CAS ]
  • 15
  • [ 189249-10-3 ]
  • C28H30N2O7 [ No CAS ]
  • 16
  • [ 189249-10-3 ]
  • C18H35N3O4 [ No CAS ]
  • 17
  • [ 189249-10-3 ]
  • Ac-Thr(<SUP>t</SUP>Bu)-trans-4-Hyp(O<SUP>t</SUP>Bu)-NHMe [ No CAS ]
  • 18
  • [ 189249-10-3 ]
  • Ac-Thr-hyp-NHMe [ No CAS ]
  • 19
  • [ 115-11-7 ]
  • [ 189249-10-3 ]
  • Fmoc-hyp(O<SUP>t</SUP>Bu)-O<SUP>t</SUP>Bu [ No CAS ]
  • 20
  • [ 71989-18-9 ]
  • [ 71989-31-6 ]
  • [ 76-05-1 ]
  • [ 189249-10-3 ]
  • H-DPro-(4S)Hyp-Glu-NH2 *TFA; Hyp=hydroxyproline [ No CAS ]
YieldReaction ConditionsOperation in experiment
General procedure: i-Pr2NEt (6 equiv) was added to a solution of Fmoc-Xaa-OH (3 equiv)and HATU (3 equiv) in a minimal amount of DMF necessary to obtaina solution. The solution of the activated amino acid (?100 mM) was the mixture was agitated for 1 h before washing with DMF (3 ×) andCH2Cl2 (3 ×).Fmoc-Deprotection; General ProcedureA solution of 20% piperidine in DMF was added to the resin pre-swollenin CH2Cl2, the reaction mixture was agitated for 10 min, drained,and the piperidine treatment was repeated for 10 min. Finally, the resin was washed with DMF (3 ×) and CH2Cl2 (3 ×).The amino acid coupling steps and the Fmoc-deprotections were monitored by qualitative Kaiser (primary amines) and chloranil tests(secondary amines). Deprotection of Side Chain Functional Groups and Cleavage of the Peptide from the Solid Support; General ProcedureA mixture of TFA/TIS/H2O (95:2.5:2.5) was added to the immobilized peptide and the suspension was agitated for 1 h and a second time for30 min. Pooling of the filtrates and removal of all volatiles under reduced pressure followed by precipitation and thorough washing with Et2O afforded the peptide as a TFA salt. The peptide was redissolved inMeCN/H2O (1:1), dried by lyophilization, and used without further purification.
  • 21
  • [ 18162-48-6 ]
  • [ 189249-10-3 ]
  • 4-(<i>tert</i>-butyl-dimethyl-silanyloxy)-pyrrolidine-1,2-dicarboxylic acid 1-(9<i>H</i>-fluoren-9-ylmethyl) ester [ No CAS ]
  • 22
  • [ 82911-69-1 ]
  • [ 618-27-9 ]
  • [ 189249-10-3 ]
Same Skeleton Products
Historical Records